Engineered extracellular vesicles for cancer therapy

X Zhang, H Zhang, J Gu, J Zhang, H Shi… - Advanced …, 2021 - Wiley Online Library
Extracellular vesicles (EVs) have emerged as a novel cell‐free strategy for the treatment of
many diseases including cancer. As a result of their natural properties to mediate cell‐to‐cell …

Recent advances in dextran-based drug delivery systems: From fabrication strategies to applications

Q Hu, Y Lu, Y Luo - Carbohydrate polymers, 2021 - Elsevier
As a natural polysaccharide, dextran and its derivatives have gained great attention in the
development of delivery systems for pharmaceutical and medical applications. In recent …

Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion

W Tian, N Lei, J Zhou, M Chen, R Guo, B Qin, Y Li… - Cell Death & …, 2022 - nature.com
Chemoresistance and metastasis are the major challenges for the current ovarian cancer
treatment. Understanding the mechanisms of ovarian cancer progression and metastasis is …

Mechanism of multidrug resistance to chemotherapy mediated by P‑glycoprotein

Y Tian, Y Lei, Y Wang, J Lai… - … Journal of Oncology, 2023 - spandidos-publications.com
Multidrug resistance (MDR) seriously limits the clinical application of chemotherapy. A
mechanism underlying MDR is the overexpression of efflux transporters associated with …

Single-cell diagnosis of cancer drug resistance through the differential endocytosis of nanoparticles between drug-resistant and drug-sensitive cancer cells

L Liu, Q Zhang, C Wang, H Guo, V Mukwaya, R Chen… - ACS …, 2023 - ACS Publications
Single-cell diagnosis of cancer drug resistance is highly relevant for cancer treatment, as it
can be used to identify the subpopulations of drug-resistant cancer cells, reveal the …

Extracellular vesicles derived from CD73 modified human umbilical cord mesenchymal stem cells ameliorate inflammation after spinal cord injury

X Zhai, K Chen, H Yang, B Li, T Zhou, H Wang… - Journal of …, 2021 - Springer
Background Spinal cord injury (SCI) is an inflammatory condition, and excessive adenosine
triphosphate (ATP) is released into the extracellular space, which can be catabolized into …

The roles of exosomes in cancer drug resistance and its therapeutic application

S Li, M Yi, B Dong, Y Jiao, S Luo… - Clinical and translational …, 2020 - Wiley Online Library
Exosomes are a category of extracellular vesicles with a size ranging from 40 to 160 nm,
which can be secreted by multiple cells in the tumor microenvironment. Exosomes serve as …

Delivery of natural products via polysaccharide-based nanocarriers for cancer therapy: a review on recent advances and future challenges

Y Jiang, C Yan, M Li, S Chen, Z Chen, L Yang… - International Journal of …, 2024 - Elsevier
Cancer, caused by uncontrolled proliferation of abnormal cells, has long been a global
public health issue. For decades, natural products have been proven to be an essential …

Current treatments and new possible complementary therapies for epithelial ovarian cancer

MP Garrido, AN Fredes, L Lobos-González… - Biomedicines, 2021 - mdpi.com
Epithelial ovarian cancer (EOC) is one of the deadliest gynaecological malignancies. The
late diagnosis is frequent due to the absence of specific symptomatology and the molecular …

[HTML][HTML] Multifunctional nanoplatforms co-delivering combinatorial dual-drug for eliminating cancer multidrug resistance

X Wei, M Song, W Li, J Huang, G Yang, Y Wang - Theranostics, 2021 - ncbi.nlm.nih.gov
Clinically, the primary cause of chemotherapy failure belongs to the occurrence of cancer
multidrug resistance (MDR), which directly leads to the recurrence and metastasis of cancer …